Welcome : Guest

Cepheid, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cepheid, Inc., which is principally involved in Molecular Diagnostics Business. Illustrated with 40 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-07967
Price: $2000
Company Type: Public
Pages: 44
Date: November 2015
Market Data Tables: 40

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Cepheid, Inc.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for North America and International......3
Table 2: Cepheid, Inc.’s Sales by Product Segment Worldwide (2013-2014) in Percentage for Clinical Systems, Clinical Reagents and Non-Clinical Systems......4
Molecular Diagnostics (MDx)......6
Table 3: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2014) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......6
Table 4: Global Molecular Diagnostics (MDx) Market by Region (2014) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......7
Table 5: Molecular Diagnostic Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......8
Table 6: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......9
Table 7: Molecular Diagnostics (MDx) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......10
Table 8: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......11
Table 9: Molecular Diagnostics (MoDx) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......12
Table 10: Molecular Diagnostics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......13
Table 11: Molecular Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......14
Table 12: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......15
Table 13: Molecular Diagnostics Market by Segment in the US (2014) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......16
Table 14: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2014) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......17
Table 15: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2014) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......18
Table 16: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2014) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......19
Table 17: Diagnostics Tests Market by Type in the US (2015) - Percentage Share Breakdown by Value for BSI Gram-Negative, BSI Gram-Positive, Clostridium Difficile, Enteric, and Respiratory Virus......20
Table 18: Molecular Diagnostics Test Market by Type in Europe (2014) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......21
Molecular Diagnostics Infectious Diseases......22
Table 19: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......22
Table 20: Infectious Disease Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......23
Molecular Clostridium difficile Equipment......24
Table 21: Molecular Clostridium Difficile Diagnostic Equipment Market by Instrument Worldwide (2014) - Percentage Share Breakdown by Value Sales for 3M Integrated Cycler, Amplivue, BD MAX, GeneXpert, ICEPlex, Illumigene, m2000, Portrait Analyzer, QIAsymphony, SmartCycler, and Verigene......24
Table 22: Molecular Clostridium Difficile Diagnostic Equipment Market by Product Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Artus Clostridium Difficile, Clostridium Difficile, Clostridium Difficile Assay, Clostridium Difficile Test, Imdx Clostridium Difficile, Progastro Clostridium Difficile, Simplexa Clostridium Difficile, Toxigenic Clostridium Difficile, and Xpert Clostridium Difficile......25
Molecular Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) Equipment......26
Table 23: Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market by Instrument Worldwide (2014) - Percentage Share Breakdown by Value Sales for AMPLICOR/4800, GeneXpert, m2000, QIAsymphony, TIGRIS/PANTHER, VIPER/ProbeTec, and Others......26
Table 24: Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Market by Product Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for AMPLICOR Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG), APTIMA Combo 2, Artus Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG), ProbeTec Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG), RealTime Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG), and Others......27
Molecular Methicillin-resistant Staphylococcus aureus (MRSA)/SA Equipment......28
Table 25: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA)/SA Diagnostic Equipment Market by Instrument Worldwide (2014) - Percentage Share Breakdown by Value Sales for BD Max, Cobas 4800, LightCycler, GeneXpert, and Others......28
Table 26: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA)/SA Diagnostic Equipment Market by Product Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for BD MAX MRSA, BD MAX StaphSR, MRSA Advanced, MRSA/SA, MRSA, SA Nasal Complete, and Others......29
Table 27: Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA) Testing Market by Type in the US (2014) - Percentage Share Breakdown by Value Sales for Chromogenic Media, Conventional Media, GeneXpert, GneOhm, LightCycler and Molecular Diagnostics Laboratory-Developed Test (MDX LDT)......30
Molecular Diagnostics (MDx)......31
Table 28: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......31
Table 29: Market Shares of Leading Molecular Diagnostics Providers Worldwide (2015) - Percentage Breakdown by Value for Abbott, Becton Dickinson, BioMerieux, Cepheid Inc, Hologic Corporation, Novartis International AG, Qiagen N.V., Roche Holding AG, Siemens AG, and Others......32
Table 30: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......33
Table 31: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......34
Molecular Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) Equipment......35
Table 32: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., F. Hoffmann-La Roche AG, Hologic Corporation, Qiagen N.V., and Others......35
Table 33: Market Shares of Leading Molecular Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gen-Probe, Inc. and Qiagen NV......36
Molecular Clostridium Difficile (C. Diff) Testing......37
Table 34: Market Shares of Leading Molecular Clostridium Difficile Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Great Basin, Hologic Corporation, Meridian Medical Technologies, Inc., Nanosphere, Inc., PrimeraDX, Inc., Qiagen N.V., Quest Diagnostics, Inc., and Others......37
Table 35: Market Shares of Leading Molecular Clostridium Difficile (C. Diff) Testing Providers the US (2014) - Percentage Breakdown by Value Sales for Becton, Dickinson and Company, Cepheid, Inc., Hologic Gen-Probe, Inc., Meridian Bioscience, Inc. and Others......38
Molecular Infectious Disease Equipment......39
Table 36: Market Shares of Leading Molecular Infectious Disease Diagnostic Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for BioMeriuex, Bruker Corporation, GenMark Diagnostics, Inc., Luminex Corporation, Nanosphere, Inc., and Others......39
Molecular Methicillin-resistant Staphylococcus aureus (MRSA)/SA Equipment......40
Table 37: Market Shares of Leading Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA)/SA Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Becton Dickinson and Co., Cepheid, Inc., F. Hoffmann-La Roche AG, and Others......40
Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT)......41
Table 38: Market Shares of Leading Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT) Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Becton, Dickinson and Company (BDX), Cepheid, Inc. (CPHD), F.Hoffmann-La Roche AG, Hologic, Inc. (HOLX), Qiagen N.V. (QGEN), and Others......41
Table 39: Cepheid, Inc.’s Sales by Segment Worldwide (2014) - Percentage Market Share Breakdown by Value for Clinical Reagents, Clinical Systems, Non-Clinical and Others......42
Table 40: Cepheid, Inc.’s Product Sales by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for International-Clinical, International-Non-Clinical, North America-Clinical and North America-Non-Clinical......43